Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousPeripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation ConditioningMelphalanCombined Modality TherapyLymphoma, Non-HodgkinLymphomaBone Marrow TransplantationTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRemission InductionSalvage TherapyHodgkin DiseaseStem CellsDisease-Free SurvivalHematopoietic Stem Cell MobilizationRecurrenceEtoposideCyclophosphamideCarmustineLiver TransplantationMyeloablative AgonistsGraft vs Host DiseaseCytarabineBone Marrow PurgingVincristineSurvival RateHematologic NeoplasmsGraft SurvivalWhole-Body IrradiationLymphoma, B-CellLymphoma, FollicularLymphoma, Mantle-CellSurvival AnalysisRetrospective StudiesHematopoietic Stem CellsThiotepaBusulfanLymphoma, Large B-Cell, DiffuseAntigens, CD34Kidney TransplantationDexamethasoneAntibodies, Monoclonal, Murine-DerivedLymphoma, T-Cell, PeripheralAmyloidosisPrognosisLeukapheresisFollow-Up StudiesCell TransplantationGranulocyte Colony-Stimulating FactorDoxorubicinThalidomideBoronic AcidsPrednisonePyrazinesAntineoplastic Agents, AlkylatingTime FactorsTransplantation ChimeraMesenchymal Stem Cell TransplantationAutograftsTissue DonorsNeoplasm, ResidualHeart TransplantationCord Blood Stem Cell TransplantationIfosfamidePodophyllotoxinLeukemia, Myeloid, AcuteImmunosuppressive AgentsLung TransplantationAntineoplastic AgentsLymphoma, T-CellMyelodysplastic SyndromesIdarubicinInduction ChemotherapyBlood Component RemovalMaintenance ChemotherapyHistocompatibility TestingAntibodies, MonoclonalFeasibility StudiesEnteropathy-Associated T-Cell LymphomaBone MarrowOrgan TransplantationProspective StudiesTransplantation ImmunologyGraft RejectionEmbryonic Stem CellsBlood Transfusion, AutologousLeukemiaHematopoiesisCell DifferentiationNeoplasms, Second PrimaryLeukemia, Plasma CellLymphoma, AIDS-RelatedMitoxantroneGraft vs Tumor EffectInfusions, Spinal